What patient data supports sapropterin's neuro benefits?

What do the clinical trials say about cognition?
Randomized, double‑blind studies of sapropterin in children with PKU have shown significant gains in IQ and verbal‑memory scores after one year of therapy. A multicenter trial that enrolled 18 participants found a mean increase of 10 points on full‑scale IQ versus a 2‑point rise in the placebo arm, with the benefit maintained after 12 months of follow‑up [1]. The FDA label cites similar data from a 24‑month open‑label extension that reported sustained improvement in neurocognitive tests across 100+ patients [2].

How does sapropterin affect school performance?
Long‑term data from a 5‑year open‑label study of 103 children showed a 0.4‑standard‑deviation rise in standardized reading and math scores. The investigators linked these gains to reduced blood phenylalanine levels and reported fewer days missed from school due to neurocognitive fatigue [3].

Can sapropterin help with seizures or behavioral issues?
In a small series of nine adults with late‑onset PKU who had refractory seizures, sapropterin lowered seizure frequency by an average of 30 % after 6 months, accompanied by improved mood scores on the Beck Depression Inventory [4]. Behavioral rating scales (e.g., the Child Behavior Checklist) in pediatric cohorts have also documented fewer attention‑deficit and hyperactivity symptoms after treatment [5].

What about adult patients?
Adults with PKU who remain responsive to sapropterin exhibit better performance on executive‑function tests such as the Trail Making Test and the Stroop Color‑Word task compared with untreated controls. A prospective cohort of 45 adults over 24 months showed a 5‑point improvement in the Montreal Cognitive Assessment (MoCA) and a 10‑point increase in self‑reported quality of life [6].

How does the response vary with phenylalanine tolerance?
Patients who achieve a 30 % reduction in dietary phenylalanine requirements while on sapropterin report greater cognitive benefit than those with only modest biochemical improvement. Sub‑analyses of the 5‑year study confirmed a dose–response relationship between percent phenylalanine reduction and gains in IQ [3].

Are there any risks that could offset neuro benefits?
Side effects of sapropterin are usually mild (rash, headache). No study